Diplomat Pharmacy Inc (DPLO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Diplomat Pharmacy Inc (DPLO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH224756D
  • |
  • Pages: 48
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Diplomat Pharmacy Inc (Diplomat Pharmacy) is a specialty pharmacy services provider that offers personalized medication therapies and various other clinical services. It also provides pharmacy benefit management and customized care management solutions, including dispensing, delivery, dosing, and reimbursement of clinically intensive and high-cost specialty drugs. The company is licensed to dispense prescriptions in all the US states and territories. Diplomat Pharmacy's solutions include patient care system, clinically based drug therapy management programs, counseling on adherence and side-effect management, drug-specific compliance programs, and clinical and administrative support services. It also provides financial assistance to patients and Hub Services for maintaining collaboration among participants in the specialty pharmacy system. Through Diplomat University, the company provides training to external professionals, including pharmacists, payors, pharmaceutical partners, and physicians, on the specialty pharmacy industry. Diplomat Pharmacy is headquartered in Flint, Michigan, the US.

Diplomat Pharmacy Inc (DPLO)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note : Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deal Details 10

Equity Offering 10

Diplomat Pharmacy Raises USD198 Million in Public Offering of Shares 10

Diplomat Pharmacy Raises USD143 Million in IPO 12

Acquisition 13

Diplomat Pharmacy Acquires Burman's Specialty Pharmacy for USD82.8 13

Diplomat Pharmacy Acquires BioRx 14

Diplomat Pharmacy Acquires MedPro Rx, Infusion Provider 16

Diplomat Pharmacy Inc-Key Competitors 17

Diplomat Pharmacy Inc-Key Employees 18

Diplomat Pharmacy Inc-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 21

Financial Announcements 21

Aug 06, 2018: Diplomat announces 2nd quarter financial result 21

May 07, 2018: Diplomat Announces Strong 1st Quarter Financial Results 23

Feb 26, 2018: Diplomat Announces 4th Quarter and 2017 Year End Financial Results; Provides 2018 Guidance 25

Nov 06, 2017: Diplomat Announces Third Quarter Financial Results 27

Aug 07, 2017: Diplomat Announces Second Quarter Financial Results 29

May 08, 2017: Diplomat Announces 1st Quarter Financial Results 31

Feb 28, 2017: Diplomat Announces 4th Quarter and 2016 Year End Financial Results; Provides Initial 2017 Guidance 33

Jan 09, 2017: Diplomat Provides 2016 Financial Guidance Update 35

Corporate Communications 36

May 10, 2018: Diplomat Pharmacy Appoints Brian Griffin as Chief Executive Officer and Chairman of the Board 36

May 08, 2018: Diplomat Pharmacy in Final Stages of CEO Search Process 37

Jan 05, 2018: Diplomat Initiates CEO Transition; Reaffirms 2017 Guidance and Provides Preliminary 2018 Outlook 38

Aug 07, 2017: Diplomat Announces A New President 40

Jun 08, 2017: Jeff Park Elected to Diplomat Board of Directors 41

Apr 13, 2017: Diplomat Promotes Executive Jennifer Cretu 42

Apr 11, 2017: Diplomat Appoints New Chief Financial Officer 43

Apr 06, 2017: Dr. Regina Benjamin Appointed to Diplomat's Board of Directors 44

Feb 14, 2017: Diplomat Enhances Corporate Governance With Appointment of Ben Wolin to Newly-Created Role of Lead Director 45

Government and Public Interest 46

Feb 21, 2018: Diplomat Managing Rising Drug Costs to Support Patients 46

Other Significant Developments 47

Apr 30, 2018: Diplomat Launches CastiaRx Industry-Leading Specialty Benefit Manager 47

Appendix 48

Methodology 48

About GlobalData 48

Contact Us 48

Disclaimer 48

List of Figures

Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

List of Tables

Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Diplomat Pharmacy Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Diplomat Pharmacy Raises USD198 Million in Public Offering of Shares 10

Diplomat Pharmacy Raises USD143 Million in IPO 12

Diplomat Pharmacy Acquires Burman's Specialty Pharmacy for USD82.8 13

Diplomat Pharmacy Acquires BioRx 14

Diplomat Pharmacy Acquires MedPro Rx, Infusion Provider 16

Diplomat Pharmacy Inc, Key Competitors 17

Diplomat Pharmacy Inc, Key Employees 18

Diplomat Pharmacy Inc, Other Locations 19

Diplomat Pharmacy Inc, Subsidiaries 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Diplomat Pharmacy Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 17970
Site License
USD 500 INR 35940
Corporate User License
USD 750 INR 53910

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com